Go ahead for Moderna in teens

The medicines regulator, Swissmedic, has given to go ahead for the Moderna vaccine to be given to adolescents aged over 12.

The decision was after trials of nearly 4,000 young people. Authorities say the reaction in younger people was the same as adults and is 93% effective.

There were some reports of side effects, lasting between 1 and 3 days – often worse after the second dose. Exactly the same as adults. 

Swissmedic is already allowing the Pfizer vaccine to be used on those over 12. 
 

More from Bitesize News

  • Bank details compromised

    British digital bank Revolut has admitted handing customer information to fraudsters who impersonated a European government agency

  • Watch theft victim speaks out

    A luxury watch dealer just across the French border from Geneva has broken his silence about a violent robbery earlier this month

  • Crans Montana hearings due before end of year

    Jessica Moretti, who ran the Constellation bar in Crans-Montana, is now living in near-isolation in the Valais village of Lens more than eight months after the deadly New Year's Eve fire

  • Better news for economy

    Switzerland's economy will grow 1.7% this year — nearly double the 0.9% expansion forecast in June, the State Secretariat for Economic Affairs said yesterday

  • Geneva budget plan unveiled

    Geneva has now put figures to its austerity plan — a CHF 546 million deficit for 2027, even after CHF 247 million in cuts

  • Summer fires increase

    Firefighters across French-speaking Switzerland tackled far more vegetation fires this summer than in any of the past five years

Download our app

  • Available on the App Store
  • Available on Google Play